Quarterlytics / Healthcare / Biotechnology / Humacyte, Inc.

Humacyte, Inc.

HUMA · NASDAQ Healthcare

Claim this profile

Ticker HUMA

Exchange NASDAQ

Sector Healthcare

Industry Biotechnology

Employees 218

Overview Coverage Annual Reports FAQ Peers Earnings Calls Financials News Management

Company Profile

Humacyte Built a Vessel From Scratch. Now It Has to Build a Business.

In May 2026, weeks after reporting the first commercial sales of its FDA-approved bioengineered blood vessel, Humacyte laid off a quarter of its workforce. The …

HUMA Jun 20, 2026